Anavex Life Sciences Corp. (AVXL)
1.255
+0.06
(+4.58%)
USD |
NASDAQ |
Nov 04, 16:00
1.255
0.00 (0.00%)
After-Hours: 20:00
Anavex Life Sciences Total Return Price : 1.255 for Nov. 4, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| November 03, 2026 | 1.20 |
| November 02, 2026 | 1.14 |
| October 30, 2026 | 1.19 |
| October 29, 2026 | 1.30 |
| October 28, 2026 | 1.30 |
| October 27, 2026 | 1.31 |
| October 26, 2026 | 1.28 |
| October 23, 2026 | 1.33 |
| October 22, 2026 | 1.36 |
| October 21, 2026 | 1.36 |
| October 20, 2026 | 1.36 |
| October 19, 2026 | 1.25 |
| October 16, 2026 | 1.31 |
| October 15, 2026 | 1.48 |
| October 14, 2026 | 1.49 |
| October 13, 2026 | 1.48 |
| October 12, 2026 | 1.51 |
| October 09, 2026 | 1.49 |
| October 08, 2026 | 1.54 |
| October 07, 2026 | 1.53 |
| October 06, 2026 | 1.60 |
| October 05, 2026 | 1.645 |
| October 02, 2026 | 1.82 |
| October 01, 2026 | 1.89 |
| September 30, 2026 | 2.02 |
| Date | Value |
|---|---|
| September 29, 2026 | 2.36 |
| September 28, 2026 | 2.35 |
| September 25, 2026 | 2.38 |
| September 24, 2026 | 2.34 |
| September 23, 2026 | 2.35 |
| September 22, 2026 | 2.47 |
| September 21, 2026 | 2.40 |
| September 18, 2026 | 2.42 |
| September 17, 2026 | 2.41 |
| September 16, 2026 | 2.36 |
| September 15, 2026 | 2.44 |
| September 14, 2026 | 2.60 |
| September 11, 2026 | 2.62 |
| September 10, 2026 | 2.66 |
| September 09, 2026 | 2.75 |
| September 08, 2026 | 2.85 |
| September 04, 2026 | 2.86 |
| September 03, 2026 | 2.85 |
| September 02, 2026 | 2.89 |
| September 01, 2026 | 2.87 |
| August 31, 2026 | 2.80 |
| August 28, 2026 | 2.99 |
| August 27, 2026 | 3.13 |
| August 26, 2026 | 3.24 |
| August 25, 2026 | 3.56 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Vaxcyte, Inc. | 65.65 |
| Foghorn Therapeutics, Inc. | 2.125 |
| Connect Biopharma Holdings Ltd. | 0.7876 |
| Caribou Biosciences, Inc. | 0.4439 |
| Arrowhead Pharmaceuticals, Inc. | 61.67 |